{
    "symbol": "CLB",
    "quarter": 4,
    "year": 2022,
    "date": "2023-02-02 11:40:21",
    "content": " For 2022, demand for laboratory services tied to the assay of crude oil and derived products in these regions declined in excess of $9 million year-over-year offsetting growth in other international regions. Additionally, the GAAP financial results for the fourth quarter include a non-cash adjustment of $1.9 million, which decreased stock compensation expense associated with performance share awards, which vested during the quarter. Now looking at the income statement, revenue from continuing operations was $127.6 million in the fourth quarter, up slightly from $126 million in the prior quarter. For the full-year of 2022, product sales revenue was of $142.8 million was up 13% from $125.9 million in 2021. EBIT ex-items for the quarter was $14.7 million, up 10% from $13.3 million last quarter, and representing an EBIT margin of approximately 12%, which is also up from 11% last quarter. Interest expense was $3.1 million in comparable to last quarter and interest expense ex-items for the full-year was $11.4 million, up slightly from $11 million in 2021. On a GAAP basis, interest expense for the full-year of 2022 was $11.6 million, up from $9.2 million in 2021, as 2021 interest expense included a $1.4 million gain associated with settling some of our interest rate hedges last year. Income from continuing operations ex-items for the quarter was $9.3 million, up 11% sequentially from $8.3 million last quarter. GAAP income from continuing operations for the quarter was $6.7 million, and for the full-year 2022 was $19.7 million. Our free cash flow continues to be focused on reducing outstanding debt, considering cash of $15.4 million, our net debt was $159.6 million at year-end, a reduction of $11.7 million this quarter, which also improved our leverage ratio to 2.29 from 2.42 at last quarter end. Looking at cash flow for the fourth quarter of 2022, cash flow from operating activities was $13.2 million, and after paying for $2 million of CapEx, our free cash flow was $11.2 million for the quarter. We project first quarter 2023 revenue to range from $125 million to $129 million and operating income of $11.5 million to $14.5 million, yielding operating margins of approximately 10%. Turning first to Reservoir Description, for the fourth quarter of 2022, revenue came in at just over $78 million down slightly compared to Q3. Operating income ex-items was $7.7 million, while operating margins were 16% for the fourth quarter of 2022 and sequential margins were more than 100%."
}